# CNS Pharmaceuticals, Inc. (CNSP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CNSP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -7.53M | $ -8.20M | $ 0 | $ 18.20M |
| 2025 | $ 0 | $ -16.23M | $ -14.16M | $ 328.6K | $ 4.52M |
| 2024 | $ 0 | $ -15.62M | $ -17.99M | $ 326.1K | $ 6.18M |
| 2023 | $ 0 | $ -20.38M | $ -15.29M | $ 300.8K | $ -4.43M |
| 2022 | $ 0 | $ -17.47M | $ -11.80M | $ 410.0K | $ 8.13M |
| 2021 | $ 0 | $ -16.68M | $ -16.10M | $ 387.8K | $ 6.62M |
| 2020 | $ 0 | $ -12.05M | $ -9.35M | $ 439.3K | $ 13.95M |
| 2019 | $ 0 | $ -5.00M | $ -4.61M | $ 0 | $ 7.60M |
| 2018 | $ 0 | $ -9.76M | $ -946.1K | $ 316.9K | $ -549.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.21 |
| Current Ratio | 5.86 |

## Other views

- [Metrics](https://sponda.capital/en/CNSP.md)
- [Charts](https://sponda.capital/en/CNSP/charts.md)
- [Compare](https://sponda.capital/en/CNSP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.